IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Anti-Cancer Drugs

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.23

h-Index

2022-2023

 98

Rank

2022-2023

 10871

SJR

2022-2023

 0.471

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Anti-Cancer Drugs
Abbreviation Anti-Cancer Drugs
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Cancer Research (Q4)
h-index 98
Overall Rank/Ranking 10871
SCImago Journal Rank (SJR) 0.471
Impact Score 2.23
Publisher Lippincott Williams and Wilkins Ltd.
Country United States
ISSN 09594973, 14735741
Best Quartile Q3
Coverage History 1990-2022




About Anti-Cancer Drugs


Anti-Cancer Drugs is a journal covering the technologies/fields/categories related to Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Cancer Research (Q4). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of Anti-Cancer Drugs is 10871. According to SCImago Journal Rank (SJR), this journal is ranked 0.471. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 98. The best quartile for this journal is Q3.

The ISSN of Anti-Cancer Drugs journal is 09594973, 14735741. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Anti-Cancer Drugs is cited by a total of 968 articles during the last 3 years (Preceding 2022).


Anti-Cancer Drugs Impact IF 2022-2023


The Impact IF 2022 of Anti-Cancer Drugs is 2.23, which is computed in 2023 as per its definition. Anti-Cancer Drugs IF is decreased by a factor of 0.03 and approximate percentage change is -1.33% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Anti-Cancer Drugs Impact IF 2023 Prediction


Impact IF 2022 of Anti-Cancer Drugs is 2.23. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Anti-Cancer Drugs. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.23
2021 2.26
2020 2.11
2019 2.38
2018 1.88
2017 1.77
2016 2.52
2015 2.41
2014 2.07

Anti-Cancer Drugs h-index


  Table Setting

Anti-Cancer Drugs has an h-index of 98. It means 98 articles of this journal have more than 98 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Anti-Cancer Drugs ISSN


The ISSN of Anti-Cancer Drugs is 09594973, 14735741. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Anti-Cancer Drugs Rank and SCImago Journal Rank (SJR)


The overall rank of Anti-Cancer Drugs is 10871. According to SCImago Journal Rank (SJR), this journal is ranked 0.471. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Anti-Cancer Drugs by Year


Year SJR
2023/2024 Coming Soon
2022 0.471
2021 0.463
2020 0.651
2019 0.636
2018 0.684
2017 0.716
2016 0.780
2015 0.783
2014 0.744

Ranking of Anti-Cancer Drugs by Year


Year Ranking
2023/2024 Coming Soon
2022 10871
2021 10705
2020 7704
2019 7745
2018 7028
2017 6600
2016 5990
2015 6068
2014 6210

Anti-Cancer Drugs Publisher


Table Setting

Anti-Cancer Drugs is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 1990-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Anti-Cancer Drugs is Anti-Cancer Drugs. This abbreviation ('Anti-Cancer Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Anti-Cancer Drugs


If your research field is/are related to Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Cancer Research (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Anti-Cancer Drugs?

Anti-Cancer Drugs latest impact IF is 2.23. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.52 (2016) and 1.77 (2017), respectively, in the last 9 years. Moreover, its average IS is 2.18 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Anti-Cancer Drugs?

The Anti-Cancer Drugs has an SJR (SCImago Journal Rank) of 0.471, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.783 in 2015 and the lowest being 0.463 in 2021. Furthermore, the average SJR of the Anti-Cancer Drugs over the previous 9-year period stands at 2.18.


What's the latest h-index of the Anti-Cancer Drugs?

The latest h-index of the Anti-Cancer Drugs is 98.


Who's the publisher of the Anti-Cancer Drugs?

The Anti-Cancer Drugs is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.


What's the current ranking of the Anti-Cancer Drugs?

The Anti-Cancer Drugs is currently ranked 10871 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5990 in 2016 and its lowest position of 10871 in 2022.


What's the abbreviation or short name for the Anti-Cancer Drugs?

The standard ISO4 abbreviation for the Anti-Cancer Drugs is Anti-Cancer Drugs.


Is the "Anti-Cancer Drugs" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Anti-Cancer Drugs is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.


What's the scope or major areas of the Anti-Cancer Drugs?

The Anti-Cancer Drugs encompasses the following areas:

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Anti-Cancer Drugs?

The Anti-Cancer Drugs is assigned the following International Standard Serial Numbers (ISSN): 09594973, 14735741.


What's the best quartile of the Anti-Cancer Drugs?

The best quartile for the Anti-Cancer Drugs is Q3 (2022).


What's the coverage history of the Anti-Cancer Drugs?

The Anti-Cancer Drugs coverage history can be summarized as follows: 1990-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Mathematical Modelling and Analysis journal 11315 Vilnius Gediminas Technical University 27 1.75
Journal of Education and Work journal 9268 Brill Academic Publishers 43 1.93
European Surgery - Acta Chirurgica Austriaca journal 16873 Springer Medizin 23 0.58
Tekstilec trade journal 19217 Faculty of Natural Sciences and Engineering, Tekstilec 14 0.73
Korean Journal of Applied Microbiology and Biotechnology journal 22033 Korean Society for Applied Microbiology 0 0.00
Biological Procedures Online journal 3350 BioMed Central Ltd. 43 6.40
Journal of Imaging Science and Technology journal 19249 Society for Imaging Science and Technology 44 0.96
Expert Review of Clinical Pharmacology journal 5241 Taylor and Francis Ltd. 53 4.10
Poljoprivreda journal 20724 Faculty of Agriculture in Osijek 14 0.67
Psycho-Oncologie journal 24009 Springer Paris 11 0.13

Check complete list




Year wise Impact Score (IS) of Anti-Cancer Drugs

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.23
2021 2.26
2020 2.11
2019 2.38
2018 1.88
2017 1.77
2016 2.52
2015 2.41
2014 2.07



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All